Skip to main content
. 2021 Oct 25;22(Suppl 4):491. doi: 10.1186/s12859-021-04400-4

Table 4.

Precision and recall for our proposed model

Germline sequence Cancer sequence
Precision Recall F-measure Precision Recall F-measure
Breast 87.1% (2.8%) 91.9% (1.6%) 89.0% (1.2%) 89.1% (1.6%) 87.2% (2.2%) 87.8% (0.7%)
Colorectal 87.8% (1.7%) 94.0% (1.6%) 90.6% (0.8%) 86.1% (3.8%) 90.8% (2.9%) 87.5% (2.2%)
Uterus 90.0% (1.8%) 72.8% (6.8%) 78.0% (5.5%) 84.9% (3.1%) 71.4% (2.8%) 76.6% (1.0%)
Brain 88.3% (4.4%) 58.6% (5.2%) 67.9% (2.2%) 77.3% (2.5%) 75.9% (3.5%) 75.6% (1.5%)
Lung 69.1% (4.9%) 79.9% (7.2%) 69.8% (2.7%) 73.7% (3.1%) 75.6% (4.0%) 73.4% (1.8%)
Kidney 81.9% (2.7%) 81.3% (2.0%) 81.3% (1.5%) 70.0% (3.8%) 76.0% (5.0%) 71.2% (3.3%)
Prostate 76.4% (6.1%) 67.3% (7.2%) 66.0% (3.7%) 72.2% (2.7%) 65.5% (3.5%) 68.1% (2.3%)

The experiment is replicated for 10 times and the number in parenthesis standard error. The bolded number are those that significantly improved in cancer sequence compared to germline sequence